The evidence for the importance of IGF1 signalling in cancers was obtained in a study showing that IGF-1 binding to IGF-1R and the downregulation of this receptor are similarly efficient in the inhibition of RCC cell lines’ growth [141,142]. Here, IGF1R is linked to renal cell carcinoma.